reiterateGMEDfinnhub
Needham Reiterates Buy Rating on Globus Medical, Inc. (GMED)
Needham reiterated its Buy rating on Globus Medical, Inc. (NYSE:GMED) on November 06, 2026.
Read moreFeatured By
Real-time context
Upgrades, downgrades, initiations, and price-target changes.
Needham reiterated its Buy rating on Globus Medical, Inc. (NYSE:GMED) on November 06, 2026.
Read moreWells Fargo reiterated its Overweight rating on Globus Medical, Inc. (NYSE:GMED) on November 06, 2026.
Read moreLeerink Partners reiterated its Outperform rating on Cencora, Inc. (NYSE:COR) on November 05, 2026.
Read moreEvercore ISI Group reiterated its Outperform rating on Emerson Electric Co. (NYSE:EMR) on November 05, 2026.
Read moreRBC Capital reiterated its Outperform rating on Emerson Electric Co. (NYSE:EMR) on November 05, 2026.
Read moreBNP Paribas reiterated its Outperform rating on Emerson Electric Co. (NYSE:EMR) on November 05, 2026.
Read moreBernstein reiterated its Outperform rating on Emerson Electric Co. (NYSE:EMR) on November 05, 2026.
Read moreWells Fargo reiterated its Overweight rating on Emerson Electric Co. (NYSE:EMR) on November 05, 2026.
Read moreKeybanc reiterated its Overweight rating on Emerson Electric Co. (NYSE:EMR) on November 05, 2026.
Read morePiper Sandler reiterated its Neutral rating on Community Healthcare Trust Incorporated (NYSE:CHCT) on November 05, 2026.
Read moreKeefe, Bruyette & Woods reiterated its Market Perform rating on TWFG, Inc. Common Stock (NASDAQ:TWFG) on November 05, 2026.
Read morePiper Sandler reiterated its Overweight rating on TWFG, Inc. Common Stock (NASDAQ:TWFG) on November 05, 2026.
Read moreBarclays reiterated its Underweight rating on Pacific Biosciences of California, Inc. (NASDAQ:PACB) on November 05, 2026.
Read morePiper Sandler reiterated its Neutral rating on Pacific Biosciences of California, Inc. (NASDAQ:PACB) on November 05, 2026.
Read moreRBC Capital reiterated its Sector Perform rating on Angi Inc. Class A Common Stock When Issued (NASDAQ:ANGIV) on November 05, 2026.
Read moreLeerink Partners reiterated its Market Perform rating on Myriad Genetics, Inc. (NASDAQ:MYGN) on November 05, 2026.
Read moreTD Cowen reiterated its Hold rating on Myriad Genetics, Inc. (NASDAQ:MYGN) on November 05, 2026.
Read moreNeedham reiterated its Buy rating on Red Violet, Inc. (NASDAQ:RDVT) on November 05, 2026.
Read moreCantor Fitzgerald reiterated its Overweight rating on Xencor, Inc. (NASDAQ:XNCR) on November 05, 2026.
Read moreDeutsche Bank analysts upgraded Frontier Group Holdings, Inc. Common Stock (NASDAQ:ULCC) from Hold to Buy on November 05, 2026.
Read more